• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Oncology, Other  • Surgery  • Surgical Interventions  • Endocrine Surgery  • Surgical Oncology  • Hepatobiliary Surgery  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Jodi M. Coates, MD; Shannon H. Beal, MD; Jack E. Russo, BA; Kimberly A. Vanderveen, MD, MAS; Steven L. Chen, MD, MBA; Richard J. Bold, MD; Robert J. Canter, MD

Arch Surg. 2009;144(9):841-847.

Objective  To examine the effect of selective preoperative biliary drainage (BD) on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Biliary drainage prior to pancreaticoduodenectomy remains controversial. Proponents argue that it facilitates referral to high-volume tertiary centers, while detractors maintain that it increases surgical morbidity and mortality.

Design  Retrospective analysis of single-institution tumor registry database.

Setting  University medical center.

Patients  From October 1, 2003, to May 31, 2008, 90 patients underwent pancreaticoduodenectomy for periampullary mass lesions.

Main Outcome Measures  Clinicopathologic data were reviewed and analyzed among patients who did and did not receive BD for their association with perioperative outcomes. ² Analysis, independent-samples t tests, and Mann-Whitney U tests were used as appropriate.

Results  Fifty-six patients (62%) underwent BD, and 34 (38%) did not. Intraoperative bile cultures were positive for 1 or more species of microorganisms in 88% of stented patients (35 of 40). There were no significant differences in fluid requirements, transfusion requirements, or surgery duration between patients who did and did not undergo BD. Estimated blood loss was increased in patients who received BD (625 mL vs 525 mL in patients who did not undergo BD; P = .03), while reoperation was significantly more common in nonstented patients (4% vs 15% in patients who did not undergo BD; P = .02). Intensive care unit stay, overall length of stay, pancreatic leak/abscess/fistula, infectious complications, postoperative percutaneous drainage, hospital readmission, and 30- and 90-day mortality were not significantly different between the 2 groups.

Conclusions  Although preoperative biliary stents may complicate the intraoperative management and lessen the postoperative complications of patients undergoing pancreaticoduodenectomy, only estimated blood loss and reoperation were significantly different in this cohort. Further study may reveal patient subgroups who may specifically benefit or suffer from preoperative biliary stenting. Currently, selective preoperative BD appears appropriate in the multidisciplinary management of patients with periampullary lesions.

Author Affiliations: Division of Surgical Oncology, UC Davis Cancer Center, Sacramento, California.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malignant Biliary Tract Obstruction: Evaluation and Therapy
Chu and Adler
J Natl Compr Canc Netw 2010;8:1033-1044.
ABSTRACT | FULL TEXT